Fair value (multi-method)
Four independent methods triangulate what PFE is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$21.91
Method range
$12.97 – $50.72
median $24.40
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $21.91 | -11.73% |
| Exit multiple | $50.72 | +104.36% |
| Analyst target | $26.89 | +8.34% |
| Graham number | $12.97 | -47.74% |
- Forward DCF$21.91
- Exit multiple$50.72
- Analyst target$26.89
- Graham number$12.97
Stock price
$24.82
FCF / share (TTM)
$0.38
3Y FCF CAGR
-25.7%
Fair value @ hist. growth
$1.17
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied FCF growth
12.8%
per year over your projection horizon
Margin of safety -2,029.8% vs hist-growth DCF
Historical 3Y CAGR
-25.7%
Your model implies
12.8%
Analyst consensus is EPS-only — no comparable FCF / share estimate to show on this basis.
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Undiscounted FCF per share over 10 years at -26% annual growth.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.0% | 11.1% | 9.6% | 7.8% | 5.6% | 2.8% |
| 5.2% | 11.9% | 10.4% | 8.7% | 6.7% | 4.2% |
| 6.2% | 15.2% | 14.1% | 12.8% | 11.4% | 9.7% |
| 7.2% | 18.2% | 17.2% | 16.2% | 15.1% | 13.8% |
| 8.2% | 20.8% | 20.0% | 19.2% | 18.2% | 17.2% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
Net debt
$66.3B
Total debt − cash
Beta
0.31
Vs market benchmark
Frequently asked questions
Pfizer (PFE) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks
- Dividend Profile6.93% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History6 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.